These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20864407)

  • 1. Regulation of ErbB receptor signalling in cancer cells by microRNA.
    Barker A; Giles KM; Epis MR; Zhang PM; Kalinowski F; Leedman PJ
    Curr Opin Pharmacol; 2010 Dec; 10(6):655-61. PubMed ID: 20864407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA regulation of growth factor receptor signaling in human cancer cells.
    Giles KM; Barker A; Zhang PM; Epis MR; Leedman PJ
    Methods Mol Biol; 2011; 676():147-63. PubMed ID: 20931396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
    Lim WK; Micklem G
    Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
    Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?
    Normanno N; Maiello MR; De Luca A
    J Cell Physiol; 2003 Jan; 194(1):13-9. PubMed ID: 12447985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB receptors: directing key signaling networks throughout life.
    Holbro T; Hynes NE
    Annu Rev Pharmacol Toxicol; 2004; 44():195-217. PubMed ID: 14744244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells.
    Pu J; McCaig CD; Cao L; Zhao Z; Segall JE; Zhao M
    J Cell Sci; 2007 Oct; 120(Pt 19):3395-403. PubMed ID: 17881501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway analysis of cancer-associated microRNA targets.
    Yang H; Zhang H; Zhu L; Wang J; Zhang C; Li D
    Int J Oncol; 2012 Dec; 41(6):2213-26. PubMed ID: 23064433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
    Sanderson MP; Dempsey PJ; Dunbar AJ
    Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ADAMS and ERBBs in lung cancer.
    Hynes NE; Schlange T
    Cancer Cell; 2006 Jul; 10(1):7-11. PubMed ID: 16843261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA.
    Gusev Y
    Methods; 2008 Jan; 44(1):61-72. PubMed ID: 18158134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
    Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
    Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21 as a key regulator of oncogenic processes.
    Selcuklu SD; Donoghue MT; Spillane C
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.